Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vaxxinity, Inc. (VAXX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vaxxinity, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1851657.
Total stock buying since 2021: $1,681,995.
Total stock sales since 2021: $3,823,325.
Total stock option exercises since 2021: $3,151,084.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 597,628 | $1,846,393 | 475,537 | $423,227 |
| 2022 | 455,784 | $1,096,305 | 735,228 | $1,976,932 | 721,409 | $2,727,857 |
| 2021 | 203,296 | $585,690 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 0 | $0 | 96,936 | $168,575 | 0 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 475,537 | $423,227 |
| 2023-01 | 0 | $0 | 500,692 | $1,677,818 | 0 | $0 |
| 2022-12 | 0 | $0 | 348,548 | $1,030,332 | 0 | $0 |
| 2022-08 | 0 | $0 | 207,680 | $496,722 | 28,645 | $16,326 |
| 2022-07 | 0 | $0 | 0 | $0 | 20,000 | $11,399 |
| 2022-06 | 362,934 | $776,037 | 179,000 | $449,878 | 0 | $0 |
| 2022-05 | 0 | $0 | 0 | $0 | 10,000 | $5,699 |
| 2022-04 | 92,850 | $320,268 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 0 | $0 | 662,764 | $2,694,433 |
| 2021-12 | 14,000 | $96,000 | 0 | $0 | 0 | $0 |
| 2021-11 | 189,296 | $489,690 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-08 | Sloss Dakin (10% Owner) | Sale | 47,961 | 1.67 | 80,094 |
| 2023-09-07 | Sloss Dakin (10% Owner) | Sale | 38,828 | 1.79 | 69,385 |
| 2023-09-06 | Sloss Dakin (10% Owner) | Sale | 10,147 | 1.88 | 19,096 |
| 2023-04-26 | Diamandis Peter (Director) | Option Ex | 475,537 | .89 | 423,227 |
| 2023-01-23 | Sloss Dakin (10% Owner) | Sale | 500,692 | 3.35 | 1,677,818 |
| 2022-12-02 | Sloss Dakin (10% Owner) | Sale | 13,741 | 2.57 | 35,286 |
| 2022-12-01 | Sloss Dakin (10% Owner) | Sale | 334,807 | 2.97 | 995,046 |
| 2022-08-25 | Sloss Dakin (10% Owner) | Sale | 33,680 | 2.33 | 78,508 |
| 2022-08-24 | Sloss Dakin (10% Owner) | Sale | 124,000 | 2.39 | 295,864 |
| 2022-08-23 | Sloss Dakin (10% Owner) | Sale | 50,000 | 2.45 | 122,350 |
| 2022-08-22 | Guirakhoo Farshad ((Former) Chief Scientific Off.) | Option Ex | 2,640 | .57 | 1,504 |
| 2022-08-15 | Guirakhoo Farshad ((Former) Chief Scientific Off.) | Option Ex | 26,005 | .57 | 14,822 |
| 2022-07-29 | Guirakhoo Farshad ((Former) Chief Scientific Off.) | Option Ex | 20,000 | .57 | 11,399 |
| 2022-06-16 | Reese Lou (Executive Chairman) | Buy | 100,000 | 1.99 | 199,300 |
| 2022-06-16 | Hu Mei Mei (See Remarks) | Buy | 100,000 | 1.99 | 199,300 |
| 2022-06-16 | United Biomedical Inc (10% Owner) | Buy | 100,000 | 1.99 | 199,300 |
| 2022-06-13 | Sloss Dakin (10% Owner) | Sale | 137,000 | 2.43 | 332,362 |
| 2022-06-10 | Sloss Dakin (10% Owner) | Sale | 42,000 | 2.80 | 117,516 |
| 2022-06-09 | Reese Lou (Executive Chairman) | Buy | 10,978 | 2.72 | 29,849 |
| 2022-06-09 | Hu Mei Mei (See Remarks) | Buy | 10,978 | 2.72 | 29,849 |
| 2022-06-09 | United Biomedical Inc (10% Owner) | Buy | 10,978 | 2.72 | 29,849 |
| 2022-06-08 | Reese Lou (Executive Chairman) | Buy | 10,000 | 2.95 | 29,530 |
| 2022-06-08 | Hu Mei Mei (See Remarks) | Buy | 10,000 | 2.95 | 29,530 |
| 2022-06-08 | United Biomedical Inc (10% Owner) | Buy | 10,000 | 2.95 | 29,530 |
| 2022-05-03 | Guirakhoo Farshad (Chief Scientific Officer) | Option Ex | 10,000 | .57 | 5,699 |
| 2022-04-27 | Reese Lou (Executive Chairman) | Buy | 4,807 | 3.58 | 17,223 |
| 2022-04-27 | Hu Mei Mei (See Remarks) | Buy | 4,807 | 3.58 | 17,223 |
| 2022-04-27 | United Biomedical Inc (10% Owner) | Buy | 4,807 | 3.58 | 17,223 |
| 2022-04-26 | Reese Lou (Executive Chairman) | Buy | 18,105 | 3.45 | 62,462 |
| 2022-04-26 | Hu Mei Mei (See Remarks) | Buy | 18,105 | 3.45 | 62,462 |
| 2022-04-26 | United Biomedical Inc (10% Owner) | Buy | 18,105 | 3.45 | 62,462 |
| 2022-04-25 | Reese Lou (Executive Chairman) | Buy | 8,038 | 3.37 | 27,071 |
| 2022-04-25 | Hu Mei Mei (See Remarks) | Buy | 8,038 | 3.37 | 27,071 |
| 2022-04-25 | United Biomedical Inc (10% Owner) | Buy | 8,038 | 3.37 | 27,071 |
| 2022-01-24 | Diamandis Peter (Director) | Option Ex | 652,764 | 4.12 | 2,688,734 |
| 2022-01-13 | Guirakhoo Farshad ((Former) Chief Scientific Off.) | Option Ex | 10,000 | .57 | 5,699 |
| 2021-12-31 | Chui James (Director) | Buy | 6,000 | 5.48 | 32,880 |
| 2021-12-10 | Chui James (Director) | Buy | 8,000 | 7.89 | 63,120 |
| 2021-11-15 | Palm Ulo (Chief Medical Officer) | Buy | 450 | 13.00 | 5,850 |
| 2021-11-15 | Diamandis Peter (Director) | Buy | 76,923 | .00 | 0 |
| 2021-11-15 | Blatt Gregory R (Director) | Buy | 76,923 | .00 | 0 |
| 2021-11-12 | Reese Lou (Executive Chairman) | Buy | 17,500 | 13.82 | 241,920 |
| 2021-11-12 | Hu Mei Mei (See Remarks) | Buy | 17,500 | 13.82 | 241,920 |
Insider trading activities including stock purchases, stock sales, and option exercises of VAXX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vaxxinity, Inc. (symbol VAXX, CIK number 1851657) see the Securities and Exchange Commission (SEC) website.